自身免疫性肝病(AILD)是一类由自身免疫系统异常引起的慢性肝脏疾病。目前,临床上最常见的AILD是自身免疫性肝炎(autoimmune hepatitis, AIH)和原发性胆汁性胆管炎(primary biliary cholangitis, PBC),若不能得到及时有效的治疗,均可发展至肝硬化。AILD的临床表现多无特异性,但其生化指标、自身抗体及组织学特点可帮助进行诊断及鉴别诊断。特别是肝脏的组织病理学在对疾病的认识过程中起到越来越重要的作用。
Autoimmune liver diseases (AILD) are chronic liver diseases caused by abnormal autoimmune sys-tem. At present, the most prevalent AILD are autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). If not treated promptly and effectively, it may develop to be cirrhosis. The clinical manifestations of AILD are not specific, but their biochemical indexes, autoantibodies and histolog-ical features can help in the diagnosis and differential diagnosis. In particular, liver histopathology plays an increasingly important role in the understanding of disease.
Autoimmune liver diseases (AILD) are chronic liver diseases caused by abnormal autoimmune system. At present, the most prevalent AILD are autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). If not treated promptly and effectively, it may develop to be cirrhosis. The clinical manifestations of AILD are not specific, but their biochemical indexes, autoantibodies and histological features can help in the diagnosis and differential diagnosis. In particular, liver histopathology plays an increasingly important role in the understanding of disease.
丁良玉,刘贵生. 常见自身免疫性肝病临床及病理研究进展Clinical and Pathological Research Progress of Common Autoimmune Liver Diseases[J]. 临床医学进展, 2022, 12(10): 8983-8989. https://doi.org/10.12677/ACM.2022.12101299
参考文献ReferencesCzaja, A.J. (2019) Examining Pathogenic Concepts of Autoimmune Hepatitis for Cues to Future Investigations and In-terventions. World Journal of Gastroenterology, 25, 6579-6606. <br>https://doi.org/10.3748/wjg.v25.i45.6579闫惠平, 刘燕敏, 张海萍. 近二十年我国自身免疫性肝病领域发展历程的回顾与展望[J]. 临床肝胆病杂志, 2022, 38(4): 737-742.王聪, 吴雄健, 黄才斌. 自身免疫性肝病的发病机制及诊疗进展[J]. 中外医疗, 2021, 40(30): 194-198.Capra, A.P., Chiara, E. and Briuglia, S. (2021) Autoimmune Hepatitis in Genetic Syndromes: A Litera-ture Review. World Journal of Hepatology, 13, 1328-1340. <br>https://doi.org/10.4254/wjh.v13.i10.1328Czaja, A.J. (2016) Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver, 10, 177-203. <br>https://doi.org/10.5009/gnl15352马雄, 王绮夏, 肖潇, 等. 自身免疫性肝炎诊断和治疗指南(2021) [J]. 临床肝胆病杂志, 2022(1): 1-8.Tanaka, A., Mori, M., Matsumoto, K., et al. (2019) Increase Trend in the Prevalence and Male-to-Female Ratio of Primary Biliary Cholangitis, Autoimmune Hepatitis, and Primary Sclerosing Cholangitis in Japan. Hepatology Research, 49, 881-889. <br>https://doi.org/10.1111/hepr.13342Mack, C.L., Adams, D., Assis, D.N., et al. (2020) Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases. Hepatology, 72, 671-722. <br>https://doi.org/10.1002/hep.31065Liberal, R., Grant, C.R., Mieli-Vergani, G., et al. (2013) Auto-immune Hepatitis: A Comprehensive Review. Journal of Autoimmunity, 41, 126-139. <br>https://doi.org/10.1016/j.jaut.2012.11.002Li, Y., Yan, L., Wang, R., et al. (2022) Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review. Clinical Reviews in Allergy & Immunology, 62, 292-300. <br>https://doi.org/10.1007/s12016-021-08833-wSebode, M., Weiler-Normann, C., Liwinski, T., et al. (2018) Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Frontiers in Immunology, 9, Article No. 609. <br>https://doi.org/10.3389/fimmu.2018.00609Sucher, E., Sucher, R., Gradistanac, T., et al. (2019) Au-toimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies. Journal of Immunology Research, 2019, Article ID: 9437043.
<br>https://doi.org/10.1155/2019/9437043Liwinski, T. and Schramm, C. (2017) Autoimmune Hepatitis-Update on Clinical Management in 2017. Clinics and Research in Hepatology and Gastroenterology, 41, 617-625. <br>https://doi.org/10.1016/j.clinre.2017.07.002王玲, 朱文静. 自身抗体检测对自身免疫性肝炎的临床诊断价值[J]. 临床医学研究与实践, 2022, 7(9): 123-126.Czaja, A.J. (2011) Performance Parameters of the Conven-tional Serological Markers for Autoimmune Hepatitis. Digestive Diseases and Sciences, 56, 545-554. <br>https://doi.org/10.1007/s10620-010-1501-1Toh, B.H. (2017) Diagnostic Autoantibodies for Autoimmune Liver Diseases. Clinical & Translational Immunology, 6, e139. <br>https://doi.org/10.1038/cti.2017.14何亚男, 郑长清. 血清自身抗体检测对自身免疫性肝病的研究进展[J]. 胃肠病学和肝病学杂志, 2020, 29(1): 104-107.韩莹, 闫惠平, 廖慧钰, 等. 抗肝肾微粒体抗体在肝病患者中的临床意义评价[J]. 中华肝脏病杂志, 2017, 25(11): 852-857.Martini, E., Abuaf, N., Cavalli, F., et al. (1988) Antibody to Liver Cytosol (Anti-LC1) in Patients with Autoimmune Chronic Active Hepatitis Type 2. Hepatology, 8, 1662-1666. <br>https://doi.org/10.1002/hep.1840080632Hennes, E.M., Zeniya, M., Czaja, A.J., et al. (2008) Simplified Crite-ria for the Diagnosis of Autoimmune Hepatitis. Hepatology, 48, 169-176. <br>https://doi.org/10.1002/hep.22322Washington, M.K. (2007) Autoimmune Liver Disease: Overlap and Outli-ers. Modern Pathology, 20, S15-S30.
<br>https://doi.org/10.1038/modpathol.3800684Gleeson, D. and Heneghan, M.A. (2011) British Society of Gas-troenterology (BSG) Guidelines for Management of Autoimmune Hepatitis. Gut, 60, 1611-1629. <br>https://doi.org/10.1136/gut.2010.235259苗琪, 陈晓宇. 自身免疫性肝炎的肝组织病理学诊断[J]. 临床肝胆病杂志, 2020, 36(4): 728-730.卞兆连, 秦刚, 陈琳, 等. 穿入现象在自身免疫性肝炎中的临床意义[J]. 肝脏, 2016, 21(9): 729-732.Sarcognato, S., Sacchi, D., Grillo, F., et al. (2021) Autoimmune Biliary Diseases: Pri-mary Biliary Cholangitis and Primary Sclerosing Cholangitis. Pathologica, 113, 170-184. <br>https://doi.org/10.32074/1591-951X-245Zeng, N., Duan, W., Chen, S., et al. (2019) Epidemiology and Clin-ical Course of Primary Biliary Cholangitis in the Asia-Pacific Region: A Systematic Review and Meta-Analysis. Hepa-tology International, 13, 788-799.
<br>https://doi.org/10.1007/s12072-019-09984-xChalifoux, S.L., Konyn, P.G., Choi, G., et al. (2017) Extrahe-patic Manifestations of Primary Biliary Cholangitis. Gut and Liver, 11, 771-780. <br>https://doi.org/10.5009/gnl16365中华医学会肝病学分会. 原发性胆汁性胆管炎的诊断和治疗指南(2021) [J]. 中华肝脏病杂志, 2022, 30(3): 264-275.Joshi, S., Cauch-Dudek, K., Heathcote, E.J., et al. (2002) Antimito-chondrial Antibody Profiles: Are They Valid Prognostic Indicators in Primary Biliary Cirrhosis? American Journal of Gastroenterology, 97, 999-1002.
<br>https://doi.org/10.1111/j.1572-0241.2002.05620.xGranito, A., Muratori, P., Quarneti, C., et al. (2012) Anti-nuclear Antibodies as Ancillary Markers in Primary Biliary Cirrhosis. Expert Review of Molecular Diagnostics, 12, 65-74. <br>https://doi.org/10.1586/erm.11.82Nakamura, M., Kondo, H., Mori, T., et al. (2007) Anti-gp210 and Anti-Centromere Antibodies Are Different Risk Factors for the Progression of Primary Biliary Cirrhosis. Hepatology, 45, 118-127. <br>https://doi.org/10.1002/hep.21472Liu, H., Norman, G.L., Shums, Z., et al. (2010) PBC Screen: An IgG/IgA Dual Isotype ELISA Detecting Multiple Mitochondrial and Nuclear Autoantibodies Specific for Primary Biliary Cirrhosis. Journal of Autoimmunity, 35, 436-442.
<br>https://doi.org/10.1016/j.jaut.2010.09.005Murillo Perez, C.F., Hirschfield, G.M., Corpechot, C., et al. (2019) Fibrosis Stage Is an Independent Predictor of Outcome in Primary Biliary Cholangitis despite Biochemical Treatment Response. Alimentary Pharmacology & Therapeutics, 50, 1127-1136. <br>https://doi.org/10.1111/apt.15533Tanaka, A. (2021) Current Understanding of Primary Biliary Cholangitis. Clinical and Molecular Hepatology, 27, 1-21.
<br>https://doi.org/10.3350/cmh.2020.0028Scheuer, P. (1967) Primary Biliary Cirrhosis. Proceedings of the Royal Society of Medicine, 60, 1257-1260.
<br>https://doi.org/10.1177/003591576706001205Ludwig, J., Dickson, E.R. and McDonald, G.S. (1978) Staging of Chronic Nonsuppurative Destructive Cholangitis (Syndrome of Primary Biliary Cirrhosis). Virchows Archiv A, Pathological Anatomy and Histology, 379, 103-112.
<br>https://doi.org/10.1007/BF00432479宋欣航, 于涓翰, 程肇平, 等. 原发性胆汁性胆管炎的病理学分期系统[J]. 临床肝胆病杂志, 2022, 38(3): 653-655.Nakanuma, Y., Zen, Y., Harada, K., et al. (2010) Application of a New Histological Staging and Grading System for Primary Biliary Cirrhosis to Liver Biopsy Specimens: Interob-server Agreement. Pathology International, 60, 167-174.
<br>https://doi.org/10.1111/j.1440-1827.2009.02500.x